Long Follow-up Time and Different Sensitivities of Cancer Types May Have Obscured the Effect of 25-hydroxyvitamin D on Cancer Incidence and Mortality Rates
Overview
Overview
Journal
Am J Clin Nutr
Publisher
Elsevier
Specialty
Nutritional Sciences
Date
2015 Jul 3
PMID
26135035
Citations
3
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Grant W J Alzheimers Dis. 2024; 100(s1):S165-S178.
PMID: 39121130 PMC: 11380269. DOI: 10.3233/JAD-240658.
Vitamin D's Role in Reducing Risk of SARS-CoV-2 and COVID-19 Incidence, Severity, and Death.
Grant W Nutrients. 2022; 14(1).
PMID: 35011058 PMC: 8747054. DOI: 10.3390/nu14010183.
Micronutrients in Oncological Intervention.
Grober U, Holzhauer P, Kisters K, Holick M, Adamietz I Nutrients. 2016; 8(3):163.
PMID: 26985904 PMC: 4808891. DOI: 10.3390/nu8030163.
References
1.
Khaw K, Luben R, Wareham N
. Serum 25-hydroxyvitamin D, mortality, and incident cardiovascular disease, respiratory disease, cancers, and fractures: a 13-y prospective population study. Am J Clin Nutr. 2014; 100(5):1361-70.
PMC: 4196486.
DOI: 10.3945/ajcn.114.086413.
View
2.
Fedirko V, Duarte-Salles T, Bamia C, Trichopoulou A, Aleksandrova K, Trichopoulos D
. Prediagnostic circulating vitamin D levels and risk of hepatocellular carcinoma in European populations: a nested case-control study. Hepatology. 2014; 60(4):1222-30.
DOI: 10.1002/hep.27079.
View
3.
Grant W
. Relation between prediagnostic serum 25-hydroxyvitamin D level and incidence of breast, colorectal, and other cancers. J Photochem Photobiol B. 2010; 101(2):130-6.
DOI: 10.1016/j.jphotobiol.2010.04.008.
View
4.
Grant W
. Effect of interval between serum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level: Implications for meta-analyses and setting vitamin D guidelines. Dermatoendocrinol. 2011; 3(3):199-204.
PMC: 3219171.
DOI: 10.4161/derm.3.3.15364.
View
5.
Grant W
. Effect of follow-up time on the relation between prediagnostic serum 25-hydroxyvitamin D and all-cause mortality rate. Dermatoendocrinol. 2012; 4(2):198-202.
PMC: 3427200.
DOI: 10.4161/derm.20514.
View